Insmed Incorporated
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
Stock Snapshot
As of today, Insmed Incorporated(INSM) shares are valued at $147.58. The company's market cap stands at 31.47B, with a P/E ratio of -24.03.
On 2026-02-11, Insmed Incorporated(INSM) stock moved within a range of $145.36 to $149.80. With shares now at $147.58, the stock is trading +1.5% above its intraday low and -1.5% below the session's peak.
Trading activity shows a volume of 938.27K, compared to an average daily volume of 2.21M.
The stock's 52-week range extends from a low of $60.40 to a high of $212.75.
The stock's 52-week range extends from a low of $60.40 to a high of $212.75.
INSM News
If you are wondering whether Insmed at around US$148.55 is still a sensible entry or hold after a strong run, the key question is how that price compares with i...
Senior executives at biopharmaceutical company Insmed (INSM) appear to have engaged in a coordinated stock sale. In a series of recent transactions, several to...
Analyst ratings
95%
of 22 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.